Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes
PHASE4Not yet recruitingINTERVENTIONAL
Enrollment
111
Participants
Timeline
Start Date
August 1, 2024
Primary Completion Date
August 1, 2025
Study Completion Date
December 1, 2025
Conditions
Diabetes Type 2Osteoporosis
Interventions
DRUG
Metformin
Metformin 1000 mg/day for 6 months
BEHAVIORAL
Lifestyle
Dietary lifestyle modifications
All Listed Sponsors
lead
King Saud University
OTHER
NCT06439758 - Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes | Biotech Hunter | Biotech Hunter